Glucose tolerance before and after renal transplantation

Nephrology Dialysis Transplantation

Volumn 25, Issue 3, 2010, Pages 985-992

  Bergrem, Henrik Andreas ^a   Valderhaug, Tone Gretland ^a   Hartmann, Anders ^a   Bergrem, Harald ^b   Hjelmesæth, Jøran ^c   Jenssen, Trond ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c VESTFOLD HOSPITAL TRUST   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Hyperglycaemia; Multiple imputation; Oral glucose tolerance test; Renal transplantation; Urea

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CYCLOSPORIN A; FUROSEMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PARATHYROID HORMONE; PHOSPHATE; PREDNISOLONE; TACROLIMUS; UREA;

ACUTE GRAFT REJECTION; ADULT; AGE DISTRIBUTION; ARTICLE; CALCIUM BLOOD LEVEL; COHORT ANALYSIS; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT; UREA BLOOD LEVEL;

ADULT; AGE FACTORS; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77649227622     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp566     Document Type: Article

References (46)

1. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International Consensus Guidelines-Proceedings of an International Expert Panel Meeting Barcelona, Spain 19 February 2003. Transplantation 2003; 75: SS3-SS24
2. Hjelmesaeth J, Hartmann A, Kofstad J, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64: 979-983
3. Hur KY, Kim MS, Kim YS, et al. Risk factors associated with the onset and progression of posttransplantation diabetes in renal allo-graft recipients. Diabetes Care 2007; 30: 609-615
4. Midtvedt K, Hjelmesaeth J, Hartmann A, et al. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 2004; 15: 3233-3239
5. DECODE Study Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardio-vascular diseases?. Diabetes Care 2003; 26: 688-696
6. Brunner EJ, Shipley MJ, Witte DR, et al. Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care 2006; 29: 26-31
7. Levitan EB, Song Y, Ford ES, et al. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Int Med 2004; 164: 2147-2155
8. Cosio FG, Kudva Y, van der Velde M, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005; 67: 2415-2421
9. Tutone VK, Mark PB, Revanur V, et al. Random blood glucose measurements and survival in nondiabetic renal transplant recipients. Transplant Proc 2004; 36: 3006-3011
10. Sharif A, Moore R, Baboolal K. Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia. Transplantation 2008; 85: 353-358
11. DeFronzo RA, Alvestrand A, Smith D, et al. Insulin resistance in uremia. J Clin Invest 1981; 67: 563-568
12. Amend WJ Jr, Steinberg SM, Lowrie EG, et al. The influence of serum calcium and parathyroid hormone upon glucose metabolism in uremia. J Lab Clin Med 1975; 86: 435-444
13. Mak RH, Bettinelli A, Turner C, et al. The influence of hyperparathy-roidism on glucose metabolism in uremia. J Clin Endocrinol Metab 1985; 60: 229-233
14. Rigalleau V, Gin H. Carbohydrate metabolism in uraemia. Curr Opin Clin Nutr Metab Care 2005; 8: 463-469
15. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus 1999 Geneva World Health Organization
16. Vartdal F, Gaudernack G, Funderud S, et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation-a fast and reliable technique. Tissue Antigens 1986; 28: 301-312
17. D'Orazio P, Burnett RW, Fogh-Andersen N, et al. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem 2005; 51: 1573-1576
18. Buttgereit F, Brand MD, Burmester GR. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glu-cocorticoid hierarchy. Biochem Pharmacol 1999; 58: 363-368
19. Horton NJ, Kleinman KP. Much ado about nothing: a comparison of missing data methods and software to fit incomplete data regression models. Am Stat 2007; 61: 79-90
20. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007; 165: 710-718
21. Bayes B, Lauzurica R, Granada ML, et al. Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation. Transplantation 2004; 78: 26-30
22. Nam JH, Mun JI, Kim SI, et al. Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 2001; 71: 1417-1423
23. Sato T, Inagaki A, Uchida K, et al. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacroli-mus or cyclosporine A-based therapy. Transplantation 2003; 76: 1320-1326
24. Wilkinson A, Davidson J, Dotta F, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005; 19: 291-298
25. Lee SW, Park GH, Lee SW, et al. Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients. Nephrol Dial Transplant 2007; 22: 2554-2562
26. Siew ED, Pupim LB, Majchrzak KM, et al. Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 2007; 71: 146-152
27. DeFronzo RA, Tobin JD, Rowe JW, et al. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 1978; 62: 425-435
28. Hampers CL, Soeldner JS, Doak PB, et al. Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest 1966; 45: 1719-1731
29. Lindall A, Carmena R, Cohen S, et al. Insulin hypersecretion in patients on chronic hemodialysis. Role of parathyroids. J Clin Endocrinol Metab 1971; 32: 653-658
30. McCaleb ML, Izzo MS, Lockwood DH. Characterization and partial purification of a factor from uremic human serum that induces insulin resistance. J Clin Invest 1985; 75: 391-396
31. Kobayashi S, Maesato K, Moriya H, et al. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 2005; 45: 275-280
32. Rigalleau V, Blanchetier V, Combe C, et al. A low-protein diet improves insulin sensitivity of endogenous glucose production in pre-dialytic uremic patients. Am J Clin Nutr 1997; 65: 1512-1516
33. Perkoff GT, Thomas CL, Newton JD, et al. Mechanism of impaired glucose tolerance in uremia and experimental hyperazotemia. Diabetes 1958; 7: 375-383
34. Balestri PL, Rindi P, Biagini M, et al. Effects of uraemic serum, urea, creatinine and methylguanidine on glucose metabolism. Clin Sci 1972; 42: 395-404
35. Johnson WJ, Hagge WW, Wagoner RD, et al. Effects of urea loading in patients with far-advanced renal failure. Mayo Clin Proc 1972; 47: 21-29
36. Kraus LM, Traxinger R, Kraus AP. Uremia and insulin resistance: N-carbamoyl-asparagine decreases insulin-sensitive glucose uptake in rat adipocytes. Kidney Int 2004; 65: 881-887
37. Haap M, Heller E, Thamer C, et al. Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. Eur J Clin Nutr 2006; 60: 734-739
38. Hagstrom E, Hellman P, Lundgren E, et al. Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. Diabetologia 2007; 50: 317-324
39. Kalaitzidis R, Tsimihodimos V, Bairaktari E, et al. Disturbances of phosphate metabolism: another feature of metabolic syndrome. Am J Kidney Dis 2005; 45: 851-858
40. Nowicki M, Fliser D, Fode P, et al. Changes in plasma phosphate levels influence insulin sensitivity under euglycemic conditions. J Clin Endocrinol Metab 1996; 81: 156-159
41. Paula FJ, Plens AE, Foss MC. Effects of hypophosphatemia on glucose tolerance and insulin secretion. Horm Metab Res 1998; 30: 281-284
42. Ghanekar H, Welch BJ, Moe OW, et al. Post-renal transplantation hypophosphatemia: a review and novel insights. Curr Opin Nephrol Hy-pertens 2006; 15: 97-104
43. Evenepoel P, Naesens M, Claes K, et al. Tertiary 'hyperphosphato-ninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant 2007; 7: 1193-2000
44. Barzi F, Woodward M. Imputations of missing values in practice: results from imputations of serum cholesterol in 28 cohort studies. Am J Epidemiol 2004; 160: 34-45
45. Gannon MC, Nuttall FQ. Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes 2004; 53: 2375-2382
46. Montori VM, Basu A, Erwin PJ, et al. Response to Hjelmesæth, et al. Diabetes Care 2002; 25: 1667-1668